NovaBay Pharmaceuticals, Inc.
NBY
$0.6001
$0.00010.02%
AMEX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 430.00K | 776.00K | 751.00K | 1.82M | 2.92M |
| Total Receivables | 389.00K | 704.00K | 547.00K | 734.00K | 680.00K |
| Inventory | 765.00K | 498.00K | 700.00K | 667.00K | 501.00K |
| Prepaid Expenses | 193.00K | 185.00K | 161.00K | 271.00K | 256.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 158.00K | 116.00K | 94.00K | 96.00K | 2.79M |
| Total Current Assets | 1.94M | 2.28M | 2.25M | 3.59M | 7.15M |
|
|
|||||
| Total Current Assets | 1.94M | 2.28M | 2.25M | 3.59M | 7.15M |
| Net Property, Plant & Equipment | 1.01M | 1.10M | 1.20M | 1.29M | 1.38M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 480.00K | 495.00K | 476.00K | 477.00K | 497.00K |
| Total Assets | 3.42M | 3.88M | 3.93M | 5.36M | 9.03M |
|
|
|||||
| Total Accounts Payable | 623.00K | 396.00K | 1.24M | 1.12M | 906.00K |
| Total Accrued Expenses | 769.00K | 396.00K | 524.00K | 521.00K | 1.17M |
| Short-term Debt | 565.00K | 51.00K | 696.00K | 1.01M | 1.14M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 398.00K | 390.00K | 382.00K | 375.00K | 368.00K |
| Total Finance Division Other Current Liabilities | 488.00K | 751.00K | 773.00K | 904.00K | 698.00K |
| Total Other Current Liabilities | 488.00K | 751.00K | 773.00K | 904.00K | 698.00K |
| Total Current Liabilities | 2.84M | 1.98M | 3.61M | 3.92M | 4.28M |
|
|
|||||
| Total Current Liabilities | 2.84M | 1.98M | 3.61M | 3.92M | 4.28M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 565.00K | 51.00K | 696.00K | 1.01M | 1.14M |
| Capital Leases | 709.00K | 821.00K | 932.00K | 1.04M | 1.11M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | 232.00K | 334.00K |
| Total Liabilities | 3.55M | 2.81M | 4.54M | 5.20M | 5.72M |
|
|
|||||
| Common Stock & APIC | 183.32M | 183.31M | 179.41M | 177.12M | 176.21M |
| Retained Earnings | -183.46M | -182.25M | -180.03M | -178.44M | -174.85M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -135.00K | 1.07M | -623.00K | -1.33M | 1.36M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 6.00K | 6.00K | 6.00K | 1.49M | 1.95M |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 6.00K | 6.00K | 6.00K | 1.49M | 1.95M |
|
|
|||||
| Total Common Equity | -135.00K | 1.07M | -623.00K | -1.33M | 1.36M |
| Total Preferred Equity | 6.00K | 6.00K | 6.00K | 1.49M | 1.95M |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -129.00K | 1.07M | -617.00K | 160.00K | 3.31M |
|
|
|||||